Novartis Secures FDA Approval for Cosentyx in Polymyalgia Rheumatica Following Positive Phase 3 Results

Cosentyx (secukinumab) doubled sustained remission rates and demonstrated steroid-sparing effects vs placebo in Phase III trial¹ Approval marks ...

November 18, 2026 | Wednesday | News
Aclaris Therapeutics Initiates Phase 2b Trial of Modzatinib for Moderate-to-Severe Lichen Planus

Dual Inhibition of ITK and JAK3 Provides Potential for Modzatinib to be the First Mechanistically Complete Oral Therapy for Lichen Planus, an Unaddressed I...

November 17, 2026 | Tuesday | News
Renaissance Pharma Secures FDA Breakthrough Therapy Designation for Daretabart in Paediatric Neuroblastoma

Designation covers daretabart in combination with induction chemotherapy for first-line treatment in paediatric patients First Breakthrough Therapy Design...

November 17, 2026 | Tuesday | News
Oculis Receives FDA IND Clearance for Privosegtor in Acute Multiple Sclerosis Relapses

FDA IND clearance opens a new era for Oculis in neurology, initiating clinical development in acute MS relapses by building directly upon the positive Phas...

November 17, 2026 | Tuesday | News
Roche Secures First FDA Approval for Gazyva in Primary Membranous Nephropathy Treatment

Roche (SIX: RO, ROP; OTCQX: RHHBY) announced that the US Food and Drug Administration (FDA) has approved Gazyva®/Gazyvaro® (obinutuzumab) for the t...

November 17, 2026 | Tuesday | News
Novo Nordisk Seeks FDA and EMA Approval for Etavopivat to Treat Sickle Cell Disease

  The FDA New Drug Application (NDA) and EMA Marketing Authorization Application (MAA) submissions for etavopivat are based on da...

November 16, 2026 | Monday | News
Ascletis Pharma Submits US FDA IND Application for ASC30_39 Oral GLP-1 and Amylin Combination to Treat Obesity

ASC30_39 FDC, a once-daily oral fixed-dose combination (FDC) tablet of small molecule GLP-1R agonist ASC30 and small molecule selective amylin receptor ago...

November 12, 2026 | Thursday | News
Salvia Advances MySalvia Implantable Migraine Therapy with Pivotal RECLAIM-II Trial in the US

Biopharma Boardroom speaks with Hubert Martens, CEO of Salvia BioElectronics, about the development of the MySalvia System, an investigational implantable ...

November 02, 2026 | Monday | Interaction
AbbVie Submits FDA Application for Etentamig in Relapsed or Refractory Multiple Myeloma

–  Etentamig is a second-generation BCMA-directed bispecific antibody T-cell engager with a clinical profile and dosing schedule that can pote...

October 29, 2026 | Thursday | News
Cognition Therapeutics Reaches FDA Agreement on Phase 3 Zervimesine Trial for Lewy Body Dementia

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerativ...

October 23, 2026 | Friday | News
IBA Treats First Patient in Clinical Trial of ConformalFLASH Proton Therapy for Head and Neck Cancer

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy so...

October 22, 2026 | Thursday | News
FDA Approves GSK and Ionis’ Hibsago for Chronic Hepatitis B Treatment

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for t...

October 22, 2026 | Thursday | News
Alvotech Secures FDA Approval for New SIMLANDI Manufacturing Process, Doubling Batch Output

Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worl...

October 21, 2026 | Wednesday | News
FDA Approves Roche’s Enspryng for Adults with Thyroid Eye Disease

FDA approval based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating a significant reduction in eye bulging (proptosis) and improvement...

October 19, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close